Endostim

Developing neurostimulation treatment for drug-refractory gastroesophageal reflux disease (GERD)

placeSt. Louis, Missouri, United States calendar_todayFounded 2009 groups4 employees language endostim.com

Innovation

26 patent families (21 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 13,718 times.

YearFilings
201513
201612
201712
20187
20197
20201
20214
20224
20235
20243
20252
20261

Social engagement

Social engagement: 598 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Prolog Ventures, Sante Ventures.

Investor typeCountShare
Venture capital556%
Private equity333%
Angel & family office111%

Recent activity

26 Mar 2026
Event
LSI USA'26
Coming soon